152 related articles for article (PubMed ID: 10491560)
21. Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
Tang JY; Pan C; Chen J; Chen H; Wu Y; Xue H; Zhao H; Gu LJ; Fu RY; Wang YP
Med Pediatr Oncol; 2002 Sep; 39(3):212-4. PubMed ID: 12210455
[No Abstract] [Full Text] [Related]
22. Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Postovsky S; Beck D; Ben-Izhak O; Arush MW
J Pediatr Hematol Oncol; 2001 May; 23(4):257-8. PubMed ID: 11846310
[No Abstract] [Full Text] [Related]
23. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.
Russell H; Hicks MJ; Bertuch AA; Chintagumpala M
Pediatr Blood Cancer; 2009 Jul; 53(1):23-7. PubMed ID: 19340853
[TBL] [Abstract][Full Text] [Related]
24. Full-dose ifosfamide can be safely administered to outpatients.
Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A
Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
[TBL] [Abstract][Full Text] [Related]
25. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Klingebiel T; Boos J; Beske F; Hallmen E; Int-Veen C; Dantonello T; Treuner J; Gadner H; Marky I; Kazanowska B; Koscielniak E
Pediatr Blood Cancer; 2008 Apr; 50(4):739-45. PubMed ID: 18286501
[TBL] [Abstract][Full Text] [Related]
26. Infantile fibrosarcoma.
Brock P; Renard M; Smet M; De Wever I; Van Daele MC
Med Pediatr Oncol; 1991; 19(3):210. PubMed ID: 2023570
[No Abstract] [Full Text] [Related]
27. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years].
Jürgens H; Bier V; Dunst J; Harms D; Jobke A; Kotz R; Kühl J; Müller-Weihrich S; Ritter J; Salzer-Kuntschik M
Klin Padiatr; 1988; 200(3):243-52. PubMed ID: 3145357
[TBL] [Abstract][Full Text] [Related]
28. Right foot congenital infantile fibrosarcoma treated only with chemotherapy.
Demir HA; Akyüz C; Varan A; Ergen FB; Büyükpamukçu M
Pediatr Blood Cancer; 2010 Apr; 54(4):618-20. PubMed ID: 19998472
[TBL] [Abstract][Full Text] [Related]
29. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
[TBL] [Abstract][Full Text] [Related]
30. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
31. Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Kirkpatrick A; Splinter TA
Eur J Cancer; 1993; 29A(2):204-7. PubMed ID: 8380697
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma in an adult: case report.
Miranda Soares PB; Quirino Filho S; Pereira DE Souza W; Ferreti Bonan PR; Martelli-Júnior H
Rev Med Chil; 2010 Sep; 138(9):1131-4. PubMed ID: 21249281
[TBL] [Abstract][Full Text] [Related]
33. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
34. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience.
Orbach D; Brennan B; De Paoli A; Gallego S; Mudry P; Francotte N; van Noesel M; Kelsey A; Alaggio R; Ranchère D; De Salvo GL; Casanova M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Ferrari A
Eur J Cancer; 2016 Apr; 57():1-9. PubMed ID: 26849118
[TBL] [Abstract][Full Text] [Related]
35. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
[TBL] [Abstract][Full Text] [Related]
37. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
38. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.
Palumbo R; Palmeri S; Gatti C; Villani G; Cesca A; Toma S
Oncol Rep; 1998; 5(1):69-72. PubMed ID: 9458296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
